Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5331 | 1570 | 39.3 | 83% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MUC1 | Author keyword | 304 | 54% | 25% | 392 |
2 | MUC1 MUCIN | Author keyword | 57 | 78% | 2% | 38 |
3 | MUC 1 | Author keyword | 17 | 37% | 2% | 36 |
4 | KL 6 MUCIN | Author keyword | 17 | 100% | 1% | 8 |
5 | MUC1 C | Author keyword | 14 | 100% | 0% | 7 |
6 | MUCIN 1 | Author keyword | 13 | 35% | 2% | 29 |
7 | POLYMORPHIC EPITHELIAL MUCIN | Author keyword | 8 | 56% | 1% | 10 |
8 | PANKOMAB | Author keyword | 8 | 100% | 0% | 5 |
9 | MUC1 CYTOPLASMIC TAIL | Author keyword | 6 | 80% | 0% | 4 |
10 | BREAST CANC BIOL GRP | Address | 6 | 24% | 1% | 20 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MUC1 | 304 | 54% | 25% | 392 | Search MUC1 | Search MUC1 |
2 | MUC1 MUCIN | 57 | 78% | 2% | 38 | Search MUC1+MUCIN | Search MUC1+MUCIN |
3 | MUC 1 | 17 | 37% | 2% | 36 | Search MUC+1 | Search MUC+1 |
4 | KL 6 MUCIN | 17 | 100% | 1% | 8 | Search KL+6+MUCIN | Search KL+6+MUCIN |
5 | MUC1 C | 14 | 100% | 0% | 7 | Search MUC1+C | Search MUC1+C |
6 | MUCIN 1 | 13 | 35% | 2% | 29 | Search MUCIN+1 | Search MUCIN+1 |
7 | POLYMORPHIC EPITHELIAL MUCIN | 8 | 56% | 1% | 10 | Search POLYMORPHIC+EPITHELIAL+MUCIN | Search POLYMORPHIC+EPITHELIAL+MUCIN |
8 | PANKOMAB | 8 | 100% | 0% | 5 | Search PANKOMAB | Search PANKOMAB |
9 | MUC1 CYTOPLASMIC TAIL | 6 | 80% | 0% | 4 | Search MUC1+CYTOPLASMIC+TAIL | Search MUC1+CYTOPLASMIC+TAIL |
10 | ANTI MUC1 ANTIBODIES | 6 | 100% | 0% | 4 | Search ANTI+MUC1+ANTIBODIES | Search ANTI+MUC1+ANTIBODIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYMORPHIC EPITHELIAL MUCIN | 208 | 59% | 15% | 231 |
2 | CARCINOMA ASSOCIATED ANTIGEN | 80 | 47% | 8% | 125 |
3 | EPITHELIAL MUCIN | 68 | 52% | 6% | 92 |
4 | ADENOCARCINOMA RECOGNIZE | 60 | 79% | 2% | 38 |
5 | EPISIALIN | 51 | 66% | 3% | 48 |
6 | EPISIALIN MUC1 | 43 | 48% | 4% | 66 |
7 | PROTEIN CORE | 40 | 56% | 3% | 49 |
8 | MUC1 C ONCOPROTEIN | 38 | 93% | 1% | 14 |
9 | TANDEM REPEAT PEPTIDE | 29 | 88% | 1% | 14 |
10 | MANNAN MUC1 FUSION PROTEIN | 23 | 86% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MUC1: a multifaceted oncoprotein with a key role in cancer progression | 2014 | 19 | 101 | 76% |
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches | 2013 | 40 | 96 | 72% |
Structure and function of the cell surface (tethered) mucins | 2008 | 210 | 146 | 51% |
MUC1 as a Potential Target in Anticancer Therapies | 2015 | 2 | 158 | 59% |
Mucins in cancer: function, prognosis and therapy | 2009 | 274 | 146 | 36% |
MUC1, the renaissance molecule | 2001 | 293 | 149 | 80% |
MUC1 and cancer | 1999 | 266 | 78 | 68% |
Cell surface-associated mucins in signal transduction | 2006 | 149 | 57 | 70% |
MUC1 and metastatic cancer Expression, function and therapeutic targeting | 2013 | 17 | 116 | 63% |
MUC1 - A target molecule for cancer therapy | 2007 | 53 | 64 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BREAST CANC BIOL GRP | 6 | 24% | 1.3% | 20 |
2 | BASIC PL IMMUNOL | 5 | 55% | 0.4% | 6 |
3 | IMMUNOL VACCINE | 4 | 23% | 1.0% | 16 |
4 | CANC BIOL MOL IMMUNOL | 4 | 16% | 1.3% | 21 |
5 | CINIBA | 4 | 36% | 0.5% | 8 |
6 | IMMUNOL ASTHMA PROGRAM | 3 | 100% | 0.2% | 3 |
7 | ALEC MYRA MARMOT HYBRIDOMA UNIT | 3 | 45% | 0.3% | 5 |
8 | INFLAMMAT TRANSLAT CLIN LUNG | 2 | 23% | 0.4% | 7 |
9 | EQUIPE MUCINES DIFFERENCIAT CANCEROGENESE EPITH | 1 | 38% | 0.2% | 3 |
10 | BASIC PL IMMUNOL CINIBA | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000261331 | MUC4//MUCIN//MUC2 |
2 | 0.0000206812 | KL 6//KREBS VON DEN LUNGEN 6//BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUG |
3 | 0.0000180521 | CA 15 3//CA 153//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN |
4 | 0.0000163055 | TN ANTIGEN//SIALYL TN//SIALYL TN ANTIGEN |
5 | 0.0000110478 | TUMOR VACCINOL//GLYCOPEPTIDES//CARL S MARVEL S |
6 | 0.0000085039 | BELAGENPUMATUCEL L//SRL172//PA MSHA |
7 | 0.0000063614 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
8 | 0.0000056247 | CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS |
9 | 0.0000044035 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
10 | 0.0000042505 | BENIGN MASTOPATHIES//PRIMARY HUMAN BREAST CANCER//BOVINE MAMMARY CELLS |